Tag Archives: CMO

Process Analytical Technology (PAT) in CRO/CMO – Why is it important?

On January 25, 2012, I attended an excellent session at the IFPAC Conference where a series of presenters including Lonza, Hovione, Merck, Pfizer, and Bristol-Myers Squibb presented the value of Process Analytical Technology (PAT) and Quality by Design (QbD) within a CRO/CMO (Contract Research Organization/Contract Manufacturing Organization). Continue reading

Robust Crystallization Processes Developed With Workstations

httpv://www.youtube.com/watch?v=vc6lEepLb-4
Continue reading